Cancer Research

Camel Milk Offers Unique Health and Digestive Benefits
Research & Development Camel Milk Offers Unique Health and Digestive Benefits

For centuries, the milk of the resilient dromedary camel has sustained nomadic cultures across the harshest deserts, and now this ancient staple is capturing the attention of nutritionists and health-conscious consumers worldwide. This is not just another fleeting wellness trend; it represents a

Do Ozempic's Results Outweigh Its Side Effects?
Research & Development Do Ozempic's Results Outweigh Its Side Effects?

With the rise of GLP-1 agonists for weight management, the real-world patient experience often diverges from the neat narratives of clinical trials. To explore this complex landscape, we are speaking with biopharma expert Ivan Kairatov. Drawing on a recent analysis of hundreds of online user

New Therapy Targets an Internal Immune System Brake
Research & Development New Therapy Targets an Internal Immune System Brake

In a landmark development for the field of oncology, cancer researchers have uncovered a crucial molecular switch that has long been hampering the immune system's capacity to effectively fight tumors, presenting a new avenue of hope for countless patients who find no benefit in existing

ASH Issues New Guidelines for Young Adult Leukemia
Research & Development ASH Issues New Guidelines for Young Adult Leukemia

The landscape of hematology is undergoing a significant transformation, driven by a new consensus that seeks to correct decades of suboptimal outcomes for a frequently overlooked demographic caught between two distinct worlds of medical care. For years, adolescents and young adults (AYAs) diagnosed

Experts Warn of Rising Lung Cancer in Never-Smokers
Research & Development Experts Warn of Rising Lung Cancer in Never-Smokers

With the landscape of lung cancer shifting dramatically, we're seeing a concerning rise in cases among people who have never smoked. This group, once considered low-risk, now represents a significant and growing portion of diagnoses, revealing a distinct form of the disease that challenges our

Adlai Nortye Begins US Trial of Novel RAS Cancer Drug
Research & Development Adlai Nortye Begins US Trial of Novel RAS Cancer Drug

For decades, cancers driven by RAS gene mutations have posed one of the most formidable challenges in oncology, with these mutations being among the most common drivers of human cancers yet notoriously difficult to target with therapeutic agents. In a significant development that offers new hope

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later